The Food and Drug Administration (FDA) has expanded the approval of Simponi ® (golimumab) to include pediatric patients weighing at least 15kg with moderate to severely active ulcerative colitis (UC).
Permethrin-treated baby wraps, used alongside bed nets, significantly reduced malaria cases children aged 6 to 18 months in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback